Journal
JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume 9, Issue 10, Pages -Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jitc-2021-002873
Keywords
immunologic surveillance; immunotherapy; tumor biomarkers; tumor microenvironment; genital neoplasms; female
Categories
Ask authors/readers for more resources
This study comparatively summarizes the humoral and cellular features of primary and metastatic EOC, analyzes their impact on disease outcome, and proposes measures to alter them in support of treatment sensitivity and superior patient survival.
Epithelial ovarian carcinoma (EOC) is a relatively rare malignancy but is the fifth-leading cause of cancer-related death in women, largely reflecting early, prediagnosis dissemination of malignant disease to the peritoneum. At odds with other neoplasms, EOC is virtually insensitive to immune checkpoint inhibitors, correlating with a tumor microenvironment that exhibits poor infiltration by immune cells and active immunosuppression. Here, we comparatively summarize the humoral and cellular features of primary and metastatic EOC, comparatively analyze their impact on disease outcome, and propose measures to alter them in support of treatment sensitivity and superior patient survival.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available